Texas Capital Bancshares Inc/Tx (TCBIO) Operating Expenses (2010 - 2026)

Texas Capital Bancshares (TCBIO) has reported Operating Expenses for 17 consecutive years, with $205.5 million the latest figure, recorded in Q2 2026.

• Quarterly Operating Expenses rose 8.0% year-over-year to $205.5 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $793.8 million (up 4.34% YoY) and the FY2025 annual result came in at $768.1 million, up 1.29% from the prior year.
• Operating Expenses fell to $205.5 million in Q2 2026 per TCBIO's latest filing, from $213.6 million in the prior quarter.
• Over the last five years, Operating Expenses for TCBIO reached as high as $213.6 million in Q1 2026 and fell as low as $153.1 million in Q1 2022.
• A 5-year average of $190.5 million and a median of $192.3 million in 2023 frame the typical range for Operating Expenses.
• Annual changes were most pronounced in 2022 — Operating Expenses jumped 45.31% — and 2024, when it decreased 14.51%.
• Year by year, Operating Expenses stood at $213.1 million in 2022, then retreated by 5.49% to $201.4 million in 2023, then retreated by 14.51% to $172.2 million in 2024, then grew by 6.99% to $184.2 million in 2025, then climbed by 11.56% to $205.5 million in 2026.
• According to Business Quant data, Operating Expenses over the past three periods registered $205.5 million, $213.6 million, and $184.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.